JAIME ACKERMAN: Open Payments
NPI 1013992544 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$44,326 in 201 payments from 19 companies in 2025. Trend: 2023 $3,732 · 2024 $26,490 · 2025 $44,326
Speaker / faculty: $30,059Travel & lodging: $8,288Food & beverage: $3,869Consulting: $2,100Education: $10
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 60 | $20,121 |
| Phathom Pharmaceuticals, Inc. | 36 | $13,530 |
| Ardelyx, Inc. | 19 | $8,924 |
| ABBVIE INC. | 33 | $592 |
| Lilly USA, LLC | 12 | $198 |
| Janssen Biotech, Inc. | 10 | $195 |
| QOL Medical, LLC | 5 | $172 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $146 |
| GENZYME CORPORATION | 4 | $101 |
| Madrigal Pharmaceuticals | 3 | $85 |
Products named: VOQUEZNA, IBSRELA, XIFAXAN, RELISTOR, TRULANCE, OMVOH, TREMFYA, RINVOQ.
Industry payments across GA — which companies pay providers there.
